Bull
Pitch Summary:
@realTimHack makes a bullish case for Namib Minerals, saying he would add at current levels if he didn’t already have exposure after spending additional time researching the company. He frames the opportunity as a major valuation disconnect, describing the business as a multi-billion-dollar gold miner with significant copper and cobalt upside despite trading around a much smaller market value. The pitch leans heavily on asset quali...
Pitch Summary:
@CapexAndChill argues that investor fears around Constellation Software heading into 2026 are misframed, especially concerns about founder transition and AI disruption. The author contends the operating model is structurally decentralized, with Mark Miller portrayed as a long-tenured insider who can run the established playbook without relying on founder “magic.” They characterize messy reported results and the large Asseco charge ...
Pitch Summary:
@StonkValue makes a bullish long-term case for Ondas Holdings, framing it as an underappreciated beneficiary of the rapidly expanding commercial drone and industrial wireless markets. The author references management projections pointing to over $1.5 billion in annual revenue by 2030, supported by existing backlog and recent acquisitions. They cite external validation from Goldman Sachs, which estimates a $100 billion commercial dr...
Pitch Summary:
@hiteshkar presents Ascent Solar as a speculative but asymmetric bet on thin-film solar as a critical enabling technology for space applications. The thesis centers on the company’s lightweight, flexible solar panels that improve satellite maneuverability and outperform silicon in high-radiation orbits such as GEO and MEO. The author highlights management claims around efficiency milestones, patented manufacturing processes, and si...
Pitch Summary:
@FjordPhil explains why they avoid Minera Alamos, arguing that multiple NI 43-101 technical reports reveal foundational data-quality and engineering-risk issues rather than normal project uncertainty. The post focuses on La Fortuna and Cerro de Oro, where the author claims key resource inputs are undermined by missing or weak physical evidence (lost drill core), questionable sampling practices, unclear check-assay provenance, and d...
Pitch Summary:
@SpaceInvestor_D argues Ascent Solar may be more than a pure speculative punt, citing a NASA-linked development pathway that could mature into commercial products for distributed space power infrastructure. The pitch frames the setup as highly asymmetric, explicitly calling it “binary,” where outcomes skew toward either failure or a large upside move. The supporting evidence is a quoted statement describing a 12-month technology ma...
Published: Jan 24, 2026
Description: WORRIED ABOUT THE MARKET? SCHEDULE YOUR FREE PORTFOLIO REVIEW with Thoughtful Money’s endorsed financial … Transcript: So again, it’s not going to be what these companies report. It’s going to be about what they say about the rest of this year and if their guidance. So two things are potentially and so here’s two […]...
Bull
Pitch Summary:
Encompass Health operates in-patient rehabilitation care hospitals for patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. Management reported quarterly results in line with expectations but also in our view a bit disappointing relative to prior quarters. However, the company’s inpatient rehab business remained on solid footing with Medicare and, in our view, the gr...
Pitch Summary:
Guardant Health provides blood-based diagnostic and monitoring tests for cancer treatment. During the quarter, management reported strong quarterly financial results. The stock also rallied after the release of disappointing data for a competitor’s blood-based cancer test, which no longer appears to be a threat for Guardant.
BSD Analysis:
Guardant Health is building diagnostics infrastructure around liquid biopsy, not just selling...
Bull
Pitch Summary:
RSSS ($2.57 avg price). The company sells a subscription product on a per seat basis to an industry that faces contraction as a result of the US federal government withdrawing funds from research and science. My divergent view is that I think it can gain share in a shrinking market, while the stock market prices this as if it can’t.
BSD Analysis:
Research Solutions is a niche content and workflow platform monetizing academic and c...
Bull
Pitch Summary:
MTRX ($7.34 avg price). The bear case against MTRX, one of our largest positions, is that despite its historically high backlog, it can’t build profitably. Recent financial results support this view. One would have to go back to pre-COVID times to understand the earnings power in the business. I believe we are near the inflection where this should become clear. If they can show profitability, which should come as soon as next quart...
Bull
Pitch Summary:
NRC ($14.45 avg price). Among our meaningful contributors in the quarter, NRC is our newest position. With 23M shares out and a current market price of $19, the company has a $430M market capitalization and including net debt, a roughly $500M enterprise value. At that price, it trades at a 13x multiple against $40M of annualized EBITDA, using the most recent quarter’s results of $10M, which I believe to be the trough. The company i...
Bull
Pitch Summary:
CCRN ($8.24 avg price). We are revisiting the nurse staffing company we first owned back in 2019 and sold when COVID comps turned negative. At $8 / share and with 32M shares out, the company has a $260M market capitalization. At its most recent quarter, the company had $99M in net cash and no debt. In December it received a $20M termination payment following its failed $615M acquisition by AYA. This leaves it with over 40% of its m...
Bull
Pitch Summary:
During the quarter, we initiated a position in Shift4 Payments, an integrated payments company with a long track record of operational execution and disciplined capital allocation. Founded in 1999 in a New Jersey basement, Shift4 has steadily built a leading position across hospitality, restaurant, and stadium end markets. While shares have declined more than 40% over the past year alongside much of the payments sector, the underly...
Bull
Pitch Summary:
We’ve owned Medical Facilities Corporation for a few years and have done very well on the back of a cash generative portfolio of hospitals and a management team that is manically focused on repurchasing shares. It’s very rare to see a management team both recognize the best use of excess capital and then stick to a plan to either reinvest it or return it to shareholders. This is one such group, and as a result I believe there remai...
Bull
Pitch Summary:
APi Group continues to execute as a steady, high-quality business operating in mission-critical fire and life-safety services. 2025 was another strong year, characterized by mid-single-digit organic growth, disciplined pricing, expanding margins, and robust cash generation. End-market demand remains healthy, and APG continues to shift the revenue mix toward recurring inspection, monitoring, and service work, which carries higher ma...
Bull
Pitch Summary:
KITS Eyecare, our e-commerce eyecare business, continued to execute exceptionally well through 2025, further validating the strength of its vertically integrated, direct-to-consumer eyecare model. KITS is exactly the type of business we want to own through volatility: founder-led, operationally disciplined and focused on long-term value creation rather than near-term optics. While valuation will occasionally invite debate, our focu...
Bull
Pitch Summary:
Natural Resource Partners, our coal royalty business, delivered another strong year in 2025, continuing its evolution into a debt-free, capital-return-focused royalty and infrastructure business. Due to the nature of the royalty business model that avoids ongoing capital expenditures and high operating costs, cash flows remained robust across the mineral rights segment, in what has been a tough environment for both met and thermal ...
Bull
Pitch Summary:
Limbach Holdings (LMB) was the Fund’s top contributor in 2020 and 2023 and has been our most lucrative investment since inception. In Q4, I added significantly to our position, once again making it a core holding for the Fund, after its shares declined 55% from their 2025 high due to concerns around a temporary demand slowdown in Q2 and Q3, largely driven by uncertainty surrounding the 2025 government shutdown. As a reminder, LMB i...
Published: Jan 24, 2026